Find News

Filter articles

Applied Filters

Showing 741 to 750 of 919 results

Purdue moves to block oxycodone drug


Purdue Pharma has sued Collegium Pharmaceutical for allegedly infringing four of its patents relating to extended release painkiller OxyContin.

Hospira targeted in generic Aloxi patent infringement case


Cancer treatment company Helsinn and pharmaceutical company Roche have sued Hospira for allegedly infringing five patents covering intravenous anti-nausea drug Aloxi.

Federal Circuit agrees that Exela infringed Ofirmev patents


The US Court of Appeals for the Federal Circuit yesterday upheld a district court's decision that pharmaceutical company Exela infringed two patents covering Cadence Pharmaceuticals’s injectable Ofirmev, used for pain relief.

BMS sues Mylan to block Reyataz generic


Bristol-Myers Squibb has sued generic drug maker Mylan for allegedly infringing a patent covering its HIV drug Reyataz.

ITMA spring conference: IP has ‘dirty’ connotations, says GSK


Intellectual property is still seen as a “dirty term” in the EU, the assistant general counsel of pharmaceutical company GlaxoSmithKline has claimed.

Delaware court rules on claim construction in Banzel patent row


A US district court yesterday gave its opinion on how a group of disputed patent claims must be construed in a patent infringement case between Eisai and Novartis and several generic drug makers.

CJEU clarifies rules on combination SPCs


An Advocate General in the Court of Justice of the European Union, Niilo Jääskinen, has clarified how the regulation for supplementary protection certificates should be interpreted concerning medicinal products made with a combination of active ingredients.

Otsuka sues Wockhardt to protect Abilify


Japanese company Otsuka Pharmaceutical has sued drugs company Wockhardt for patent infringement at the US District Court for the District of New Jersey.

US Supreme Court refuses to hear Tamiflu ‘double patenting’ case


The US Supreme Court yesterday refused to hear a case between Californian pharmaceutical company Gilead and India-based Natco that concerns ‘double patenting’.

German court rules against Eli Lilly in Alimta patent case

EU, Germany09-03-2015

The German Court of Appeal has ruled that Indianapolis-based Eli Lilly’s European “vitamin regimen” patent for lung cancer injection Alimta would not be infringed by Actavis’s generic version.

Showing 741 to 750 of 919 results